Find Ingavirin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 219694-63-0, Ingamine, Imidazolyl ethanamide pentandioic acid, Pentanedioic acid imidazolyl ethanamide, 4-{[2-(1h-imidazol-5-yl)ethyl]carbamoyl}butanoic acid, 3cm03muj69
Molecular Formula
C10H15N3O3
Molecular Weight
225.24  g/mol
InChI Key
KZIMLUFVKJLCCH-UHFFFAOYSA-N
FDA UNII
3CM03MUJ69

Ingavirin
Imidazolyl Ethanamide Pentandioic Acid is an orally bioavailable small molecule, with potential hematopoiesis inducing and antiviral activities. Upon oral administration, myelo001 stimulates the differentiation of bone marrow cells of the leukocytic, lymphocytic, and erythrocytic lineages, and prevents apoptosis of hematopoietic cells. This prevents chemotherapy-induced neutropenia (CIN), inhibits the risk of infections, increases tolerance and allows for the continuation of the neutropenia-inducing chemotherapeutic agent. In addition, myelo 001 has antiviral properties.
1 2D Structure

Ingavirin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[2-(1H-imidazol-5-yl)ethylamino]-5-oxopentanoic acid
2.1.2 InChI
InChI=1S/C10H15N3O3/c14-9(2-1-3-10(15)16)12-5-4-8-6-11-7-13-8/h6-7H,1-5H2,(H,11,13)(H,12,14)(H,15,16)
2.1.3 InChI Key
KZIMLUFVKJLCCH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=C(NC=N1)CCNC(=O)CCCC(=O)O
2.2 Other Identifiers
2.2.1 UNII
3CM03MUJ69
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-(2-(1h-imidazol-4-yl)ethylamino)-5-oxopentanoic Acid

2. Dicarbamin

3. Imidazolyl Ethanamide Pentandioic Acid

4. Pentanedioic Acid Imidazolyl Ethanamide

5. Vitaglutam

2.3.2 Depositor-Supplied Synonyms

1. 219694-63-0

2. Ingamine

3. Imidazolyl Ethanamide Pentandioic Acid

4. Pentanedioic Acid Imidazolyl Ethanamide

5. 4-{[2-(1h-imidazol-5-yl)ethyl]carbamoyl}butanoic Acid

6. 3cm03muj69

7. Pentanoic Acid, 5-[[2-(1h-imidazol-4-yl)ethyl]amino]-5-oxo-

8. 4-[2-(1h-imidazol-4-yl)-ethylcarbamoyl]-butyric Acid

9. Dicarbamin

10. Vitaglutam

11. Pentanoic Acid, 5-((2-(1h-imidazol-4-yl)ethyl)amino)-5-oxo-

12. Agn-pc-0mw29y

13. 4-([2-(1h-imidazol-5-yl)ethyl]carbamoyl)butanoic Acid

14. 5-[2-(1h-imidazol-5-yl)ethylamino]-5-oxopentanoic Acid

15. Unii-3cm03muj69

16. Schembl8282926

17. Chembl4297291

18. Schembl18381264

19. 5-(2-(1h-imidazol-4-yl)ethylamino)-5-oxopentanoic Acid

20. Dtxsid90433141

21. Zinc40493529

22. Akos002807987

23. Db11944

24. D11250

25. F75163

26. Imidazolyl Ethanamide Pentandioic Acid [who-dd]

27. Q27257036

28. 4-{[2-(1h-imidazol-5-yl)ethyl]carbamoyl}butanoicacid

29. 6-(2-(1h-imidazol-4-yl)ethylamino)-5-oxohexanoic Acid

30. 5-((2-(1h-imidazol-5-yl)ethyl)amino)-5-oxopentanoic Acid

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 225.24 g/mol
Molecular Formula C10H15N3O3
XLogP3-0.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count7
Exact Mass225.11134135 g/mol
Monoisotopic Mass225.11134135 g/mol
Topological Polar Surface Area95.1 Ų
Heavy Atom Count16
Formal Charge0
Complexity246
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


4.2 ATC Code

J - Antiinfectives for systemic use

J05 - Antivirals for systemic use

J05A - Direct acting antivirals

J05AX - Other antivirals

J05AX21 - Pentanedioic acid imidazolyl ethanamide


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty